Literature DB >> 8063210

Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

M J Weldon1, J D Maxwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8063210      PMCID： PMC1374829          DOI： 10.1136/gut.35.7.867

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  64 in total

1.  Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis.

Authors:  Z Toossi; J R Sedor; J P Lapurga; R J Ondash; J J Ellner
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 2.  The role of activated T lymphocytes in gastrointestinal disease.

Authors:  T T MacDonald
Journal:  Clin Exp Allergy       Date:  1990-05       Impact factor: 5.018

3.  Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.

Authors:  J G Williams; L E Hughes; M B Hallett
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

4.  HIV and arthritis.

Authors:  A M Solinger; E V Hess
Journal:  J Rheumatol       Date:  1990-04       Impact factor: 4.666

5.  T cells in inductive and effector compartments of the intestinal mucosal immune system of nonhuman primates differ in lymphokine mRNA expression, lymphokine utilization, and regulatory function.

Authors:  S P James; W C Kwan; M C Sneller
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

6.  Macrophage turnover in Crohn's disease and ulcerative colitis.

Authors:  G Meuret; A Bitzi; B Hammer
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

7.  Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro.

Authors:  G Pizzolo; C Vincenzi; F Vinante; A Rigo; D Veneri; M Chilosi; S Dusi; G Poli; R Zambello; G Semenzato
Journal:  Cell Immunol       Date:  1992-04-15       Impact factor: 4.868

8.  Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells.

Authors:  Y Ohashi; T Takeshita; K Nagata; S Mori; K Sugamura
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

Review 9.  Interleukin-2 and the IL-2 receptor: new insights into structure and function.

Authors:  W A Kuziel; W C Greene
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

10.  Preliminary report: cyclosporin in treatment of severe active ulcerative colitis.

Authors:  S Lichtiger; D H Present
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321
View more
  4 in total

1.  Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice.

Authors:  L G Axelsson; E Landström; T J Goldschmidt; A Grönberg; A C Bylund-Fellenius
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

2.  Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies.

Authors:  S Dionne; J Hiscott; I D'Agata; A Duhaime; E G Seidman
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

3.  Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats.

Authors:  Mehmet Yalniz; Ulvi Demirel; Cemal Orhan; Ibrahim Halil Bahcecioglu; Ibrahim Hanefi Ozercan; Cem Aygun; Mehmet Tuzcu; Kazim Sahin
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  Preventive Effect of Lactobacillus acidophilus XY27 on DSS-Induced Ulcerative Colitis in Mice.

Authors:  Tiantian Hu; Hongxia Wang; Chengzheng Xiang; Jianfei Mu; Xin Zhao
Journal:  Drug Des Devel Ther       Date:  2020-12-22       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.